Abstract
The current study aimed to remit the immunoreactivity of glycinin and β-conglycinin through the methods of glycation. The immunoreactivity of the glycated soybean antigen proteins after hydrolyzed was analyzed in vitro. Then in the in vivo trial, 24 crossbred castrated piglets were allocated to four dietary treatments in a complete block design, each treatment with six replicates. From day 29–43, the control groups were fed diets with 4% unglycated glycinin or β-conglycinin, while the treatment groups received diets containing 4% glycated glycinin or β-conglycinin. Generally, the immunoreactivity removal rate increased in all products as time went on both in vitro and in vivo. The immunoreactivity residual rate of unglycated soybean antigen protein was much higher than those of the glycated ones in vitro. Moreover, pepsin and trypsin affected glycated glycinin and glycated β-conglycinin in a different way.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
